Share
6,617 Posts.
lightbulb Created with Sketch. 2074
clock Created with Sketch. 07/06/24
19:05
Share
Originally posted by smashintins
↑
By doing a lazy Friday arvo chatgdp search current SoC for GBM after surgery is Temozolomide which is worth around $200m in sales. Patent expiry was in 2013 before which annual sales were approx $920 million. So one could take a 3-5x sales figure from that and discount what you think is appropriate for the trial stage. My hope and guess would be well north of $15m.
Expand
Great opportunity to accumulate whilst confidence is low ....and people are speculating on " conspiracy theories etc "
(20min delay)